The Claim
Reduction in hepatic fat content independently predicts improvements in serum gamma-glutamyltransferase, alanine aminotransferase, circulating chemerin, and glycated hemoglobin in adults with abdominal obesity and dyslipidemia, even after accounting for loss of visceral adipose tissue.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with abdominal obesity and dyslipidemia, a decrease in liver fat is associated with measurable improvements in blood markers of liver function, inflammation, and blood sugar control, regardless of how much visceral fat is lost.
See the scientific wording
Reduction in hepatic fat content independently predicts improvements in serum gamma-glutamyltransferase, alanine aminotransferase, circulating chemerin, and glycated hemoglobin in adults with abdominal obesity and dyslipidemia, even after accounting for loss of visceral adipose tissue.
When fat builds up in the liver, it damages liver cells and causes them to leak enzymes and send out inflammatory signals. Reducing this fat fixes the liver cells, stops the leaks, lowers inflammation, and improves how the body handles sugar. This happens even if fat around the belly doesn't change.
What the research says
1 studyWhen people with belly fat and high cholesterol lose liver fat—even if their belly fat doesn’t change much—their liver and blood sugar markers get better. This study shows that losing liver fat is what really helps, not just losing belly fat.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.